More intensive hepatitis C virus care models promote adherence among people who inject drugs with active drug use: The PREVAIL study is a research paper published in Journal of Viral Hepatitis (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Gilead Sciences
Grant: IN‐337‐1779
National Institutes of Health
Grant: R01DA034086
National Institutes of Health
Grant: K99/R00DA043011
NIDA NIH HHS
Grant: R00 DA043011
NIDA NIH HHS
Grant: K24 DA051807
NIDA NIH HHS
Grant: K99 DA043011
NCATS NIH HHS
Grant: UL1 TR002556
National Institutes of Health
Grant: 5R00DA043011-05
Advance Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants Living
National Institutes of Health
Grant: 7R01DA034086-07
Intensive Models of HCV Care for Injection Drug Users
FWCI
0.62
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals